Keywords: Fujifilm Diosynth Biotechnologies, ThromboGenics, Jetrea, Ocriplasmin, Vitromacular adhesion

Fujifilm Diosynth to manufacture ocriplasmin for ThromboGenics

Article | 20 November 2012

Print This

In a second major deal in less than a month, Japanese firm Fujifilm Diosynth Biotechnologies has added another licensed product ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in